The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global baby diaper rash cream market reached a value of US$ 1.28 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 6.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
A diaper rash, medically known as diaper dermatitis, causes skin irritation due to chemical allergies, prolonged wetness, bacterial infection and diaper friction. It can also alter the sleeping pattern of the infant/baby, reduce the frequency of urination or defecation, and lead to severe skin inflammation. At present, there is an increase in the demand for the baby diaper rash cream as it helps in calming these symptoms and preventing them from reoccurring by forming a protective barrier between the baby’s skin and potential irritants. It is generally manufactured using beeswax, zinc oxide, mineral oil and skin soothers.
Due to the increasing consciousness among parents about the harmful impact of utilizing baby products in the long term, there has been a gradual shift toward natural products that are free from parabens, phthalates, silicones, petrochemicals, artificial preservatives and other synthetic additives. In line with this, they are also investing in organic products, which are produced using ingredients such as sunflower seed, jojoba, almond and calendula oils. These organic variants offer antifungal and antibacterial qualities as well as aid in reconditioning and softening the baby’s skin. Furthermore, some of the leading manufacturers operating in the industry are investing in promotional campaigns to retain a competitive edge and expand their existing consumer base. Additionally, the proliferation of supermarkets and hypermarkets, in confluence with the burgeoning e-commerce sector, is anticipated to increase product accessibility, particularly in the developing economies.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global baby diaper rash cream market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on gender, type and distribution channel.
Breakup by Gender:
The male segment currently exhibits a clear dominance in the market.
Breakup by Type:
At present, zinc oxide-based creams represent the most commonly utilized product as they help in forming a protective layer around rashes.
Breakup by Distribution Channel:
Supermarkets and hypermarkets account for the majority of the total market share as they offer a one-stop-shop experience to buyers.
On the geographical front, Asia Pacific enjoys the leading position in the market due to various product launches in the region.
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Some of these players are:
|Base Year of the Analysis||2020|
|Segment Coverage||Gender, Type, Distribution Channel, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Turkey, Saudi Arabia, Iran, United Arab Emirates, Brazil, Mexico, Argentina, Colombia, Chile, Peru|
|Companies Covered||Beiersdorf AG, Bepanthen (Bayer AG), Bio Veda Action Research Co., Burt's Bees (The Clorox Company), Cetaphil, Chicco USA Inc. (Artsana USA Inc.), Johnson & Johnson, Mission Pharmacal Company, Mustela, NUK, Sebapharma GmbH & Co. KG, Sudocrem (Teva Pharmaceutical Industries Ltd), Summers Laboratories Inc., The Himalaya Drug Company, W.S. Badger Company and Weleda International|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at